LSUHSC’s Dr. Nick Goeders Talks About Possible Breakthrough Drug [AUDIO]
It's working name is EMB001 and according to Dr. Nicholas Goeders, if ongoing trials prove successful, this drug could change the way addictions of all kinds are treated.
Dr. Goeders, head of the Department of Pharmacology, Toxicology and Neuroscience at Shreveport's LSU Health Science Center says that in studies, EMB001 has shown to 'block the cravings that are associated with drug addiction'.
So, how does EMB001 work? Is it currently being tested on humans and, if so, how long until this game changing drug might be on the market?
Dr. Goeders, a Shreveport native and Jesuit / Loyola High grad, explains it all in this 710 KEEL interview with Robert J Wright and Erin McCarty.